Cargando…
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
In patients with chronic fibrosing interstitial lung disease (ILD), a progressive fibrosing phenotype (PF-ILD) may develop, but information on the frequency and characteristics of this population outside clinical trials is lacking. We assessed the characteristics and outcomes of patients with PF-ILD...
Autores principales: | Nasser, Mouhamad, Larrieu, Sophie, Si-Mohamed, Salim, Ahmad, Kaïs, Boussel, Loic, Brevet, Marie, Chalabreysse, Lara, Fabre, Céline, Marque, Sébastien, Revel, Didier, Thivolet-Bejui, Françoise, Traclet, Julie, Zeghmar, Sabrina, Maucort-Boulch, Delphine, Cottin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411897/ https://www.ncbi.nlm.nih.gov/pubmed/32943410 http://dx.doi.org/10.1183/13993003.02718-2020 |
Ejemplares similares
-
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
por: Nasser, Mouhamad, et al.
Publicado: (2021) -
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
por: Cottin, Vincent, et al.
Publicado: (2021) -
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
por: Nasser, Mouhamad, et al.
Publicado: (2021) -
Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases
por: Si-Mohamed, Salim A., et al.
Publicado: (2022) -
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)